Business Standard

Zydus Lifesciences Ltd Announcements

BY EXCHANGE :

ANNOUNCEMENTSUBJECTATTACHMENTBROADCAST DATE
Announcement under Regulation 30 (LODR)-Press Release / Media Release Zydus receives final approval from USFDA for Valsartan Tablets.23/07/2024
Announcement under Regulation 30 (LODR)-Press Release / Media Release Zydus receives approval from COFEPRIS of Mexico to market Bhava TM (Bevacizumab ...Read More22/07/2024
Announcement under Regulation 30 (LODR)-Newspaper Publication Copy of newspaper publication19/07/2024
Announcement under Regulation 30 (LODR)-Press Release / Media Release Completion of USFDA inspection at transdermal manufacturing site19/07/2024
Announcement under Regulation 30 (LODR)-Press Release / Media Release Zydus receives final approval from the USFDA for its NDA Zituvimet TM XR (sitagl...Read More19/07/2024
Update Received report from the USFDA for its injectable manufacturing facility at Jaro...Read More18/07/2024
Board Meeting Intimation for Approval Of Unaudited Financial Results For The Quarter Ended On June 30 2024 Zydus Lifesciences Ltdhas informed BSE that the meeting of the Board of Director...Read More18/07/2024
Announcement under Regulation 30 (LODR)-Newspaper Publication Copy of newspaper publication18/07/2024
Announcement under Regulation 30 (LODR)-Press Release / Media Release Zydus announces non-exclusive patent licensing agreement with Takeda for Vault (...Read More17/07/2024
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate Intimation of loss of share certificate under Reg 39(3) of the SEBI (Listing Obl...Read More16/07/2024
Reg. 34 (1) Annual Report. Annual Report12/07/2024
Announcement under Regulation 30 (LODR)-Newspaper Publication Newspaper publication post dispatch of Annual Report12/07/2024
Demand Order From GST Demand Order from GST12/07/2024
Business Responsibility and Sustainability Reporting (BRSR) Business Responsibility and Sustainability Report for the FY 2023-202411/07/2024
Reg. 34 (1) Annual Report. Annual Report for the FY 2023-202411/07/2024
Notice Of Annual General Meeting To Be Held On August 9 2024 Notice of Annual General Meeting to be held on August 9 202411/07/2024
Announcement under Regulation 30 (LODR)-Press Release / Media Release (Revised) Zydus receives final approval from USFDA for Sacubitril and Valsartan Tablets.10/07/2024
Announcement under Regulation 30 (LODR)-Press Release / Media Release Zydus receives tentative approval from USFDA for Diroximel Fumarate Delayed-Rele...Read More10/07/2024
Announcement under Regulation 30 (LODR)-Press Release / Media Release Zydus receives final approval from USFDA for Sacubitril and Valsartan Tablets.10/07/2024
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 Certificate under regulation 74(5) of the SEBI (Depositories and Participants) R...Read More10/07/2024

Load more